# K-ACCELERATE (SPOT-MAS in people with symptoms)

Source: https://onco.cc/trials/k-accelerate/  
OnCo record `k-accelerate` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Vietnamese study of whether the SPOT-MAS blood test can help sort out which people with worrying symptoms have one of five common cancers.

## Summary

K-ACCELERATE (NCT06391749) is an observational study sponsored by Gene Solutions with University of Medicine and Pharmacy at Ho Chi Minh City. Its primary objective is the performance of SPOT-MAS in detecting cancer in symptomatic people; a secondary objective is its feasibility as a primary-care triage test.

The registry record, read on 29 October 2026, gives its status as enrolling by invitation, with an estimated 1,000 participants, a start on 30 July 2024 and primary completion expected in July 2026.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Also known as: K-ACCELERATE
- Registry id: NCT06391749
- Phase: observational
- Setting: People in Vietnam with symptoms or signs of breast, colorectal, gastric, liver or lung cancer, tested with SPOT-MAS as a triage test
- Sponsor: Gene Solutions with University of Medicine and Pharmacy at Ho Chi Minh City
- Enrolled: 1000

## Sources

- ClinicalTrials.gov NCT06391749: https://clinicaltrials.gov/study/NCT06391749

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [SPOT-MAS](https://onco.cc/drugs/spot-mas/)
- companies: [Gene Solutions](https://onco.cc/companies/gene-solutions/)

---
JSON: https://onco.cc/api/v1/entities/k-accelerate.json